PubRank

Gerd Assmann

Author PubWeight™ 86.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003 8.61
2 C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012 6.39
3 From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003 3.94
4 Lipid-related markers and cardiovascular disease prediction. JAMA 2012 3.91
5 Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003 3.48
6 Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networks. Int J Epidemiol 2002 2.48
7 HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004 2.36
8 The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008 1.88
9 HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002 1.87
10 FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007 1.46
11 Phytanic acid accumulation is associated with conduction delay and sudden cardiac death in sterol carrier protein-2/sterol carrier protein-x deficient mice. J Cardiovasc Electrophysiol 2004 1.43
12 PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. Clin Chem Lab Med 2008 1.42
13 Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2006 1.33
14 Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet 2006 1.29
15 Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 2003 1.28
16 The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res 2008 1.27
17 Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004 1.25
18 Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol 2014 1.20
19 Response to Conroy et al. SCORE Project. Eur Heart J 2003 1.20
20 Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002 1.16
21 Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002 1.13
22 Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun 2002 1.12
23 Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol 2007 1.11
24 HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol 2008 1.11
25 Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 2002 1.05
26 Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence. Expert Rev Cardiovasc Ther 2005 1.04
27 Branched chain fatty acids induce nitric oxide-dependent apoptosis in vascular smooth muscle cells. J Biol Chem 2002 1.02
28 Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007 0.98
29 The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet 2006 0.96
30 Cell surface localization of ABCG1 does not require LXR activation. Arterioscler Thromb Vasc Biol 2006 0.96
31 Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. J Biol Chem 2004 0.95
32 Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J Biol Chem 2004 0.94
33 Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 2006 0.94
34 Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids. Trends Cardiovasc Med 2005 0.94
35 Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J Biol Chem 2003 0.92
36 ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett 2004 0.91
37 High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells. Biochem Biophys Res Commun 2003 0.91
38 Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol. FEBS Lett 2007 0.91
39 The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women. J Clin Endocrinol Metab 2002 0.90
40 Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007 0.89
41 Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr 2002 0.86
42 Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem 2005 0.85
43 LCAT deficiency: molecular and phenotypic characterization of an Italian family. J Nephrol 2006 0.84
44 Assessment of human MAPCs for stem cell transplantation and cardiac regeneration after myocardial infarction in SCID mice. Exp Hematol 2010 0.84
45 Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol (Oxf) 2004 0.84
46 Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study. Eur J Hum Genet 2006 0.84
47 Genes, diet and public health. Genes Nutr 2007 0.83
48 Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors. Atherosclerosis 2005 0.82
49 The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 2005 0.82
50 Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase. Biochem Biophys Res Commun 2005 0.81
51 Dietary mono- and polyunsaturated fatty acids similarly increase plasma apolipoprotein A-IV concentrations in healthy men and women. J Nutr 2003 0.80
52 Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux. Clin Endocrinol (Oxf) 2003 0.80
53 The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes. Biochem Biophys Res Commun 2002 0.80
54 Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care. Curr Med Res Opin 2010 0.80
55 The mutagenically separated polymerase chain reaction is a rapid and reliable method for genotyping of the tumour necrosis factor-alpha promoter polymorphism (-308 G/A). Clin Chim Acta 2002 0.79
56 Electrocardiographic risk stratification in families with congenital long QT syndrome. Eur Heart J 2006 0.79
57 Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia. J Nutr 2004 0.78
58 Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure. Clin Cardiol 2008 0.78
59 Cholesterol absorption inhibitor Ezetimibe blocks uptake of oxidized LDL in human macrophages. Biochem Biophys Res Commun 2004 0.77
60 Expression and functional characterization of ABCG1 splice variant ABCG1(666). FEBS Lett 2006 0.77
61 Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart disease. Nutr Metab Cardiovasc Dis 2006 0.76
62 Inflammation in atherosclerosis, not yet time for a paradigm shift? Curr Opin Lipidol 2003 0.75
63 Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification. BMJ 2003 0.75
64 "Polypill" to fight cardiovascular disease: interpretation of trial data is optimistic. BMJ 2003 0.75
65 Normal platelet reactivity in apolipoprotein E (apo E)-deficient mouse. Platelets 2006 0.75
66 REPEATED MEASUREMENTS OF BLOOD PRESSURE AND CHOLESTEROL IMPROVES CARDIOVASCULAR DISEASE RISK PREDICTION: AN INDIVIDUAL-PARTICIPANT-DATA META-ANALYSIS. Am J Epidemiol 2017 0.75
67 [Cardiovascular risk factors--where do these come from? Interview by Nicola von Lutterotti]. Dtsch Med Wochenschr 2005 0.75